This page is been managed directly by the hospital. Any communications initiated will be directly responded by the hospital only.

    Dr. Ayla Sifoglu

    Neurodegenerative disease · Epilepsy

    36 Yrs

    Acibadem Bakirkoy Hospital

    İstanbul, Turkey


    Foundation year






    Medical staff


    Dr. Ahmet Arnaz is a cardiovascular surgeon at Acibadem Bakirkoy Hospital. He graduated from the Ondokuz Mayis University's Faculty of Medicine in 1994. After graduation, he worked at the Emergency department of Gazipasa State Hospital for one year. He then moved to Antalya, where he worked at the emergency department of Antalya State Hospital from 1995 to 2003. Dr. Ahmet Arnaz then decided to pursue his passion and specialized in Cardiovascular Surgery from the Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital in 2009. Right after completing his residency, Dr. Ahmet Arnaz went to Texas Heart Institute for further training. After returning to Turkey, he joined Acibadem Group of Hospitals in 2011 and has been working there since then. Dr. Ahmet Arnaz is a well-skilled surgeon with more than 27 years of experience in medicine. He has a special clinical interest in Aortic Aneurysm, Heart Failure Surgery, and the treatment of Varicose Veins. He is a respectable and prestigious member of the Turkish Cardiovascular Surgery Association, European Association of Cardiothoracic Surgery, Phlebology Association, and Turkish Medical Association. In addition to being an excellent surgeon, Dr. Ahmet Arnaz is also interested in research and innovation in cardiovascular medicine. He has published various publications, including the article published in the Journal of Cardiac Surgery in 2009 with the title "Preserved Pleural Integrity Provides Better Respiratory Function and Pain Score After Coronary Surgery." He also presented an article at the 18 Congress of the World Society of Cardiothoracic Surgeons held on April 30-May 3, 2008, in Kos Island, Greece. This article was titled "Candida parapsilosis tricuspid native valve endocarditis: 3-year follow-up after surgical treatment."